Author

H. Qing

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Wang· 2 shared B. K. Hilliard· 2 shared C. J. Booth· 2 shared S. Ryu· 2 shared V. D. Dixit· 2 shared A. M. Ring· 1 shared A. Swaminathan· 1 shared C. B. Wilen· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Wang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Type I Interferon Limits Viral Dissemination-Driven Clinical Heterogeneity in a Native Murine Betacoronavirus Model of COVID-19

H. Qing, L. Sharma, B. K. Hilliard, X. Peng, A. Swaminathan, J. Tian, K. Israni-Winger, C. Zhang, D. Leao, S. Ryu, V. Habet, L. Wang, X. Tian, S. Ishibe, L. H. Young, , A. Wang

This study establishes a murine model of COVID-19 using MHV-A59 and shows that type-I interferons limit viral dissemination, reducing lethality and recapitulating key clinical features.

bioRxiv · Sep 11, 2020 · PreprintImmunology

Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model

S. Ryu, I. Shchukina, Y.-H. Youm, H. Qing, B. K. Hilliard, T. Dlugos, X. Zhang, Y. Yasumoto, C. J. Booth, C. Fernandez-Hernando, Y. Suarez, K. M. Khanna, T. Horvath, M. O. Dietrich, M. Artyomov, , V. D. Dixit

This study shows that a ketogenic diet reduces inflammation and improves outcomes in aged mice infected with a coronavirus, suggesting potential therapeutic benefits for elderly COVID-19 patients.

bioRxiv · Sep 11, 2020 · PreprintImmunology